Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age.
Donfrancesco A, Jenkner A, Castellano A, Ilari I, Milano GM, De Sio L, Cozza R, Fidani P, Deb G, De Laurentis C, Inserra A, Dominici C. Donfrancesco A, et al. Among authors: de laurentis c, de sio l. Acta Paediatr Suppl. 2004 May;93(445):6-11. doi: 10.1111/j.1651-2227.2004.tb03048.x. Acta Paediatr Suppl. 2004. PMID: 15176712 Clinical Trial.
Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: pharmacological rationale and clinical response.
Donfrancesco A, De Ioris MA, McDowell HP, De Pasquale MD, Ilari I, Jenkner A, Castellano A, Cialfi S, De Laurentis C, Dominici C. Donfrancesco A, et al. Among authors: de laurentis c, de pasquale md, de ioris ma. Pediatr Blood Cancer. 2010 Jan;54(1):55-61. doi: 10.1002/pbc.22219. Pediatr Blood Cancer. 2010. PMID: 19821523
Microscopic neoplastic thrombosis in localised nephroblastoma: does it influence outcome?
De Ioris MA, Aloi I, Camassei FD, Ravà L, Boldrini R, De Sio L, De Laurentis C, Castellano A, Crocoli A, Locatelli F, Jenkner A, Inserra A. De Ioris MA, et al. Among authors: de laurentis c, de sio l. Eur J Cancer. 2011 Mar;47(5):718-23. doi: 10.1016/j.ejca.2010.10.028. Epub 2010 Dec 2. Eur J Cancer. 2011. PMID: 21129949
Bevacizumab in pediatric patients: how safe is it?
de Pasquale MD, Castellano A, de Sio L, de Laurentis C, Mastronuzzi A, Serra A, Cozza R, Jenkner A, de Ioris MA. de Pasquale MD, et al. Among authors: de laurentis c, de ioris ma, de sio l. Anticancer Res. 2011 Nov;31(11):3953-7. Anticancer Res. 2011. PMID: 22110225
Neurovesical dysfunction in children after treating pelvic neoplasms.
Mosiello G, Gatti C, De Gennaro M, Capitanucci ML, Silveri M, Inserra A, Milano GM, De Laurentis C, Boglino C. Mosiello G, et al. Among authors: de laurentis c, de gennaro m. BJU Int. 2003 Aug;92(3):289-92. doi: 10.1046/j.1464-410x.2003.04326.x. BJU Int. 2003. PMID: 12887486
Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma.
De Bernardi B, Carli M, Casale F, Corciulo P, Cordero di Montezemolo L, De Laurentis C, Bagnulo S, Brisigotti M, Marchese N, Garaventa A, et al. De Bernardi B, et al. Among authors: de laurentis c. J Clin Oncol. 1992 Dec;10(12):1870-8. doi: 10.1200/JCO.1992.10.12.1870. J Clin Oncol. 1992. PMID: 1453202
High dose peptichemio in pretreated neuroblastoma.
Garaventa A, De Bernardi B, Cordero Di Montezemolo L, Pastore G, De Laurentis C, Nardi E, Casale F, Mancini A, Loiacono G. Garaventa A, et al. Among authors: de bernardi b, de laurentis c. Anticancer Res. 1989 Jul-Aug;9(4):1157-60. Anticancer Res. 1989. PMID: 2817797
55 results